Patent · US Active

Treatment of metastatic breast cancer

US7976842B2 · kind B2 · utility

2Cited by

0References

6Claims

0Family size

Assignee

Micromet AG · DE

Inventors

Carsten Reinhardt · Birkenfeld, DE
Robert Saller · Egglkofen, DE

Key dates

Filing date	Feb 9, 2007
Grant date	Jul 12, 2011
Priority date	—
Expiry date	Oct 8, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/505
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the use of an anti-EpCAM antibody for the manufacture of a medicament for the treatment of metastatic breast cancer. The present invention further relates to a method of treating metastatic breast cancer comprising administering said anti-EpCAM antibody.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.